PAHC Earnings & Financial Statements
Phibro Animal Health Corporation
$37.93
+$1.12(+3.04%)
66
Overall
90
Value
54
Tech
55
Quality
Market Cap
$1.54B
Volume
283.08K
52W Range
$28.25 - $60.08
Target Price
$44.75
PAHC earnings and financial statements: Phibro Animal Health Corporation's income statement, balance sheet and cash flow statement, annual and quarterly.
PAHC Annual Financial Statements
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $1.30B | $1.02B | $977.89M | $942.26M | $833.35M |
| Cost of revenue | $896.27M | $704.59M | $679.65M | $656.86M | $561.97M |
| Operating income | $110.47M | $53.31M | $71.85M | $78.99M | $74.87M |
| EBITDA | $146.85M | $66.67M | $104.13M | $117.72M | $110.21M |
| Net income | $48.26M | $2.42M | $32.61M | $49.17M | $54.38M |
| EPS (diluted) | $1.19 | $0.06 | $0.81 | $1.21 | $1.34 |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | $1.36B | $982.18M | $971.40M | $931.70M | $841.33M |
| Total liabilities | $1.08B | $725.54M | $688.89M | $669.26M | $602.80M |
| Shareholders’ equity | $285.68M | $256.64M | $282.51M | $262.44M | $238.53M |
| Cash and equivalents | $68.04M | $70.61M | $41.28M | $74.25M | $50.21M |
| Long-term debt | $736.17M | $458.29M | $452.54M | $417.93M | $382.71M |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating cash flow | $80.12M | $87.59M | $13.31M | $31.65M | $48.31M |
| Capital expenditure | -$38.29M | -$41.24M | -$51.79M | -$37.04M | -$29.32M |
| Free cash flow | $41.83M | $46.36M | -$38.48M | -$5.39M | $18.99M |
| Dividends paid | $19.45M | $19.44M | $19.44M | $19.44M | $19.43M |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | PAHC | $37.93 | +3.0% | 283.08K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Phibro Animal Health Corporation Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW